Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

This article has been updated


Alzheimer's disease constitutes a rising threat to public health. Despite extensive research in cellular and animal models, identifying the pathogenic agent present in the human brain and showing that it confers key features of Alzheimer's disease has not been achieved. We extracted soluble amyloid-β protein (Aβ) oligomers directly from the cerebral cortex of subjects with Alzheimer's disease. The oligomers potently inhibited long-term potentiation (LTP), enhanced long-term depression (LTD) and reduced dendritic spine density in normal rodent hippocampus. Soluble Aβ from Alzheimer's disease brain also disrupted the memory of a learned behavior in normal rats. These various effects were specifically attributable to Aβ dimers. Mechanistically, metabotropic glutamate receptors were required for the LTD enhancement, and N-methyl D-aspartate receptors were required for the spine loss. Co-administering antibodies to the Aβ N-terminus prevented the LTP and LTD deficits, whereas antibodies to the midregion or C-terminus were less effective. Insoluble amyloid plaque cores from Alzheimer's disease cortex did not impair LTP unless they were first solubilized to release Aβ dimers, suggesting that plaque cores are largely inactive but sequester Aβ dimers that are synaptotoxic. We conclude that soluble Aβ oligomers extracted from Alzheimer's disease brains potently impair synapse structure and function and that dimers are the smallest synaptotoxic species.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Monomeric and oligomeric Aβ is detected in brain extracts of humans with clinically and neuropathologically typical late-onset Alzheimer's disease.
Figure 2: Soluble Aβ extracted from Alzheimer's disease brain alters hippocampal synapse physiology and learned behavior.
Figure 3: Soluble dimers are the smallest Aβ assembly form in human brain to acutely perturb synapse physiology.
Figure 4: Insoluble amyloid cores contain Aβ dimers with synaptotoxic potential but are not readily released.

Similar content being viewed by others

Change history

  • 15 July 2008

    Nature Medicine; doi:10.1038/nm1782; published online 22 June 2008; corrected 15 July 2008. In the version of this article initially published online, the authors inadvertently included the blot in Figure 1b (right) a second time as Figure 1a (right). In addition, the authors would like to clarify the white areas within Figure 3a (top and bottom) in the figure legend. These errors have been corrected for all versions of the article.


  1. Lorenzo, A. & Yankner, B.A. β-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc. Natl. Acad. Sci. USA 91, 12243–12247 (1994).

    Article  CAS  Google Scholar 

  2. Lambert, M.P. et al. Diffusible, nonfibrillar ligands derived from Aβ1–42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 95, 6448–6453 (1998).

    Article  CAS  Google Scholar 

  3. Mucke, L. et al. High-level neuronal expression of Aβ 1–42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20, 4050–4058 (2000).

    Article  CAS  Google Scholar 

  4. Morgan, D. et al. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408, 982–985 (2000).

    Article  CAS  Google Scholar 

  5. Walsh, D.M. et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535–539 (2002).

    Article  CAS  Google Scholar 

  6. Walsh, D.M., Tseng, B.P., Rydel, R.E., Podlisny, M.B. & Selkoe, D.J. The oligomerization of amyloid β protein begins intracellularly in cells derived from human brain. Biochemistry 39, 10831–10839 (2000).

    Article  CAS  Google Scholar 

  7. McLean, C.A. et al. Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann. Neurol. 46, 860–866 (1999).

    Article  CAS  Google Scholar 

  8. Kuo, Y.M. et al. Water-soluble Aβ (N-40, N-42) oligomers in normal and Alzheimer disease brains. J. Biol. Chem. 271, 4077–4081 (1996).

    Article  CAS  Google Scholar 

  9. Lue, L.F. et al. Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 155, 853–862 (1999).

    Article  CAS  Google Scholar 

  10. Schulz, P.E., Cook, E.P. & Johnston, D. Changes in paired-pulse facilitation suggest presynaptic involvement in long-term potentiation. J. Neurosci. 14, 5325–5337 (1994).

    Article  CAS  Google Scholar 

  11. Kemp, N. & Bashir, Z.I. Long-term depression: a cascade of induction and expression mechanisms. Prog. Neurobiol. 65, 339–365 (2001).

    Article  CAS  Google Scholar 

  12. Dudek, S.M. & Bear, M.F. Homosynaptic long-term depression in area CA1 of hippocampus and effects of N-methyl-d-aspartate receptor blockade. Proc. Natl. Acad. Sci. USA 89, 4363–4367 (1992).

    Article  CAS  Google Scholar 

  13. Mulkey, R.M. & Malenka, R.C. Mechanisms underlying induction of homosynaptic long-term depression in area CA1 of the hippocampus. Neuron 9, 967–975 (1992).

    Article  CAS  Google Scholar 

  14. Tyszkiewicz, J.P. & Yan, Z. β-Amyloid peptides impair PKC-dependent functions of metabotropic glutamate receptors in prefrontal cortical neurons. J. Neurophysiol. 93, 3102–3111 (2005).

    Article  CAS  Google Scholar 

  15. Hsieh, H. et al. AMPAR removal underlies Aβ-induced synaptic depression and dendritic spine loss. Neuron 52, 831–843 (2006).

    Article  CAS  Google Scholar 

  16. Lacor, P.N. et al. Aβ oligomer–induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J. Neurosci. 27, 796–807 (2007).

    Article  CAS  Google Scholar 

  17. Shankar, G.M. et al. Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor–dependent signaling pathway. J. Neurosci. 27, 2866–2875 (2007).

    Article  CAS  Google Scholar 

  18. Fox, G.B., O'Connell, A.W., Murphy, K.J. & Regan, C.M. Memory consolidation induces a transient and time-dependent increase in the frequency of neural cell adhesion molecule polysialylated cells in the adult rat hippocampus. J. Neurochem. 65, 2796–2799 (1995).

    Article  CAS  Google Scholar 

  19. O'Sullivan, N.C. et al. Temporal change in gene expression in the rat dentate gyrus following passive avoidance learning. J. Neurochem. 101, 1085–1098 (2007).

    Article  CAS  Google Scholar 

  20. Terry, R.D. et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572–580 (1991).

    Article  CAS  Google Scholar 

  21. Tavazoie, S.F., Alvarez, V.A., Ridenour, D.A., Kwiatkowski, D.J. & Sabatini, B.L. Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat. Neurosci. 8, 1727–1734 (2005).

    Article  CAS  Google Scholar 

  22. Walsh, D.M. et al. Certain inhibitors of synthetic amyloid β-peptide (Aβ) fibrillogenesis block oligomerization of natural Aβ and thereby rescue long-term potentiation. J. Neurosci. 25, 2455–2462 (2005).

    Article  CAS  Google Scholar 

  23. Masters, C.L. et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82, 4245–4249 (1985).

    Article  CAS  Google Scholar 

  24. Selkoe, D.J., Abraham, C.R., Podlisny, M.B. & Duffy, L.K. Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer's disease. J. Neurochem. 46, 1820–1834 (1986).

    Article  CAS  Google Scholar 

  25. Roher, A.E., Palmer, K.C., Yurewicz, E.C., Ball, M.J. & Greenberg, B.D. Morphological and biochemical analyses of amyloid plaque core proteins purified from Alzheimer disease brain tissue. J. Neurochem. 61, 1916–1926 (1993).

    Article  CAS  Google Scholar 

  26. Martins, I.C. et al. Lipids revert inert Aβ amyloid fibrils to neurotoxic protofibrils that affect learning in mice. EMBO J. 27, 224–233 (2008).

    Article  CAS  Google Scholar 

  27. Spires, T.L. et al. Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J. Neurosci. 25, 7278–7287 (2005).

    Article  CAS  Google Scholar 

  28. Cleary, J.P. et al. Natural oligomers of the amyloid-β protein specifically disrupt cognitive function. Nat. Neurosci. 8, 79–84 (2005).

    Article  CAS  Google Scholar 

  29. Lesne, S. et al. A specific amyloid-β protein assembly in the brain impairs memory. Nature 440, 352–357 (2006).

    Article  CAS  Google Scholar 

  30. Klyubin, I. et al. Amyloid β protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization. J. Neurosci. 28, 4231–4237 (2008).

    Article  CAS  Google Scholar 

Download references


We thank Elan for the gifts of 2G3 and 21F12 antibodies. Mass spectrometry was performed by the Taplin Biological Mass Spectrometry Facility (S. Gygi). We thank X. Sun and W. Qiu for performing ELISA. We thank members of the Selkoe laboratory for helpful comments. G.M.S. recognizes L. Gurumani for support and encouragement. This work was supported by the US National Institute on Aging grant AG R01 027443 (D.J.S., G.M.S., S.L., T.H.M., N.E.S.), Science Foundation Ireland grant 03/IN3/B403C (C.M.R., A.G.-M.) and Wellcome Trust grant 067660 (D.M.W., I.S.). B.L.S. was supported by the McKnight and Ellison Foundations as well as by a Lefler Small Grant Fund.

Author information

Authors and Affiliations



G.M.S. designed and performed experiments and prepared the manuscript; S.L. designed and performed electrophysiology experiments; T.H.M. and N.E.S. performed biochemical experiments; A.G.-M. performed passive avoidance experiments; I.S. generated mutant Aβ peptide; C.A.L., F.M.B. and M.A.F. characterized human brain tissue; M.J.R. designed electrophysiology experiments; C.M.R. designed passive avoidance experiments; D.M.W. designed biochemical experiments; B.L.S. designed electrophysiology and morphology experiments; and D.J.S. designed experiments and prepared the manuscript.

Corresponding author

Correspondence to Dennis J Selkoe.

Ethics declarations

Competing interests

D.J.S. is a founding scientist of Athena Neurosciences and consultant to Elan.

Supplementary information

Supplementary Text and Figures

Supplementart Figs. 1–7, Supplementary Table 1 and Supplementary Methods (PDF 5052 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shankar, G., Li, S., Mehta, T. et al. Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14, 837–842 (2008).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing